{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:52:34Z","timestamp":1789786354751,"version":"4.0.1"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/toxsci\/kfx253","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T15:17:44Z","timestamp":1510586264000},"page":"23-33","source":"Crossref","is-referenced-by-count":41,"title":["Asking the Right Questions With Animal Models: Methionine- and Choline-Deficient Model in Predicting Adverse Drug Reactions in Human NASH"],"prefix":"10.1093","volume":"161","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-7259","authenticated-orcid":false,"given":"Nathan J","family":"Cherrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"key\n\t\t\t\t20171227085525_kfx253-B1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1478-3231.2005.01191.x","article-title":"Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis","volume":"26","year":"2006","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1665-2681(19)31170-6","article-title":"The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease","volume":"14","year":"2015","journal-title":"Ann. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.yexmp.2015.11.008","article-title":"Induction of CYP2E1 in non-alcoholic fatty liver diseases","volume":"99","year":"2015","journal-title":"Exp. Mol. Pathol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jhep.2004.08.020","article-title":"Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease","volume":"41","year":"2004","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jhep.2010.03.016","article-title":"Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis","volume":"53","year":"2010","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2015.02.018","article-title":"Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?","volume":"418","year":"2015","journal-title":"Mol. Cell. Endocrinol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","article-title":"Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role","volume":"35","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MPG.0b013e3181f9b3a0","article-title":"Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease","volume":"52","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B10","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/00498250010021684","article-title":"Determining the best animal model for human cytochrome P450 activities: A comparison of mouse, rat, rabbit, dog, micropig, monkey and man","volume":"30","year":"2000","journal-title":"Xenobiotica"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B11","first-page":"673","article-title":"NASH: A glance at the landscape of pharmacological treatment","volume":"15","year":"2016","journal-title":"Ann. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B12","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: Distinct clinicopathologic meanings","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B13","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","year":"2016","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B14","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","article-title":"Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: Impact on mitochondrial S-adenosyl-L-methionine and glutathione","volume":"285","year":"2010","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2010.04.031","article-title":"Hepatocellular ballooning in NASH","volume":"53","year":"2010","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/dmd.113.055996","article-title":"Modeling human nonalcoholic steatohepatitis-associated changes in drug transporter expression using experimental rodent models","volume":"42","year":"2014","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1124\/dmd.114.062703","article-title":"Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis","volume":"43","year":"2015","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrd.2016.188","article-title":"Nonalcoholic steatohepatitis (NASH) drugs market","volume":"15","year":"2016","journal-title":"Nat. Rev. Drug Discov"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B19","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","year":"2012","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B20","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1021\/acs.jafc.6b01663","article-title":"Effects of nonalcoholic fatty liver disease on hepatic CYP2B1 and in vivo bupropion disposition in rats fed a high-fat or methionine\/choline-deficient diet","volume":"64","year":"2016","journal-title":"J. Agric. Food Chem"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1478-3231.2007.01524.x","article-title":"Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis","volume":"27","year":"2007","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B22","doi-asserted-by":"crossref","first-page":"17.","DOI":"10.1124\/jpet.116.238790","article-title":"Impact of nonalcoholic fatty liver disease on toxicokinetics of tetrachloroethylene in mice","volume":"361","year":"2017","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B23","doi-asserted-by":"crossref","first-page":"3305.","DOI":"10.2337\/db14-1947","article-title":"Mechanism of altered metformin distribution in nonalcoholic steatohepatitis","volume":"64","year":"2015","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/jpet.113.211284","article-title":"Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expression","volume":"348","year":"2014","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jhep.2014.02.021","article-title":"Synergistic interaction between genetics and disease on pravastatin disposition","volume":"61","year":"2014","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","article-title":"Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression","volume":"28","year":"2012","journal-title":"Curr. Opin. Gastroenterol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jhep.2006.08.025","article-title":"NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis","volume":"46","year":"2007","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B28","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1124\/dmd.106.009670","article-title":"Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts","volume":"34","year":"2006","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1124\/jpet.114.220764","article-title":"Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis","volume":"352","year":"2015","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/jpet.116.234310","article-title":"Biliary elimination of pemetrexed is dependent on Mrp2 in rats: Potential mechanism of variable response in nonalcoholic steatohepatitis","volume":"358","year":"2016","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study","volume":"50","year":"2009","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/cpt.66","article-title":"Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis","volume":"97","year":"2015","journal-title":"Clin. Pharmacol. Ther"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2009.04.002","article-title":"Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats","volume":"613","year":"2009","journal-title":"Eur. J. Pharmacol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B34","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease","volume":"37","year":"2009","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0168-8278(03)00376-3","article-title":"Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis","volume":"39","year":"2003","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B36","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/oby.21855","article-title":"Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model","volume":"25","year":"2017","journal-title":"Obesity"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/toxsci\/kfu156","article-title":"Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis","volume":"142","year":"2014","journal-title":"Toxicol. Sci"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B38","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1124\/dmd.112.048439","article-title":"Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease","volume":"41","year":"2013","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B39","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1124\/dmd.110.035006","article-title":"Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease","volume":"38","year":"2010","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B40","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1124\/dmd.111.041012","article-title":"Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease","volume":"39","year":"2011","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1124\/dmd.111.041095","article-title":"Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis","volume":"40","year":"2012","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/460208a","article-title":"Toxicology for the twenty-first century","volume":"460","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cld.2016.08.005","article-title":"Adverse drug reactions: Type A (intrinsic) or type B (idiosyncratic)","volume":"21","year":"2017","journal-title":"Clin. Liver Dis"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","year":"2009","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2362.33.s2.5.x","article-title":"Organic anion\u2010transporting polypeptide (OATP) transporter family and drug disposition","volume":"33","year":"2003","journal-title":"Eur. J. Clin. Invest"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: Function and regulation","volume":"62","year":"2010","journal-title":"Pharmacol. Rev"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B47","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00210-006-0040-y","article-title":"Pharmacogenomics of human OATP transporters","volume":"372","year":"2006","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/jhep.2003.50316","article-title":"Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1586\/egh.11.8","article-title":"Hepatocellular ballooning in nonalcoholic steatohepatitis: The pathologist\u2019s perspective","volume":"5","year":"2011","journal-title":"Expert Rev. Gastroenterol. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bcp.2016.11.006","article-title":"Transcription factor binding site enrichment analysis predicts drivers of altered gene expression in nonalcoholic steatohepatitis","volume":"122","year":"2016","journal-title":"Biochem. Pharmacol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B51","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/dmd.111.040592","article-title":"Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease","volume":"39","year":"2011","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B52","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1440-1746.2008.05543.x","article-title":"Animal models of NASH: Getting both pathology and metabolic context right","volume":"23","year":"2008","journal-title":"J. Gastroenterol. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2008.03.026","article-title":"MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes","volume":"49","year":"2008","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B54","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","year":"2000","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/labinvest.3700489","article-title":"Intrahepatic insulin resistance in a murine model of steatohepatitis: Effect of PPAR\u03b3 agonist pioglitazone","volume":"87","year":"2007","journal-title":"Lab. Investig"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B56","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1478-3231.2009.02022.x","article-title":"Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease","volume":"29","year":"2009","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B57","doi-asserted-by":"crossref","first-page":"e21840.","DOI":"10.1002\/jbt.21840","article-title":"In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice","volume":"31","year":"2017","journal-title":"J. Biochem. Mol. Toxicol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B58","doi-asserted-by":"crossref","first-page":"1317.","DOI":"10.1124\/dmd.117.077644","article-title":"Pediatric cytochrome P450 activity alterations in nonalcoholic steatohepatitis","volume":"45","year":"2017","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B59","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1124\/dmd.107.015107","article-title":"Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease","volume":"35","year":"2007","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jbt.20177","article-title":"Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis","volume":"21","year":"2007","journal-title":"J. Biochem. Mol. Toxicol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1357-2725(99)00139-9","article-title":"S-Adenosylmethionine","volume":"32","year":"2000","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B62","first-page":"1","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B63","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.nutr.28.061807.155438","article-title":"Methionine metabolism and liver disease","volume":"28","year":"2008","journal-title":"Annu. Rev. Nutr"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B65","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/clpt.2008.302","article-title":"Impact of infectious and inflammatory disease on cytochrome P450? Mediated drug metabolism and pharmacokinetics","volume":"85","year":"2009","journal-title":"Clin. Pharmacol. Ther"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B66","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00535-015-1148-y","article-title":"The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease","volume":"51","year":"2016","journal-title":"J. Gastroenterol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","year":"2000","journal-title":"Regul. Toxicol. Pharmacol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/psp4.12185","article-title":"Population pharmacokinetics of morphine in patients with nonalcoholic steatohepatitis (NASH) and healthy adults","volume":"6","year":"2017","journal-title":"CPT Pharmacometrics Syst. Pharmacol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B69","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/bmj.316.7140.1295","article-title":"Adverse drug reactions","volume":"316","year":"1998","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B70","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hep.21614","article-title":"CCAAT\/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis","volume":"45","year":"2007","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B71","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.105.085456","article-title":"Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice","volume":"314","year":"2005","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B72","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","year":"2008","journal-title":"J. Lipid Res"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","year":"2004","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B100","year":"2014"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B74","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hep.20999","article-title":"JNK1 but not JNK2 promotes the development of steatohepatitis in mice","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B75","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/dmrr.666","article-title":"Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease","volume":"22","year":"2006","journal-title":"Diabetes Metab. Res. Rev"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B76","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425255.1.3.429","article-title":"Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination","volume":"1","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B77","doi-asserted-by":"crossref","first-page":"G283.","DOI":"10.1152\/ajpgi.00296.2009","article-title":"Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice","volume":"298","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"key\n\t\t\t\t20171227085525_kfx253-B78","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.25630","article-title":"Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis","volume":"56","year":"2012","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B79","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/026119290803600310","article-title":"Estimates for worldwide laboratory animal use in 2005","volume":"36","year":"2008","journal-title":"Altern. Lab. Anim"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B80","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.2005.071118","article-title":"Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice","volume":"55","year":"2006","journal-title":"Gut"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B81","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/apt.14210","article-title":"Review article: New treatments in non-alcoholic fatty liver disease","volume":"46","year":"2017","journal-title":"Aliment. Pharmacol. Ther"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B82","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.med.58.072905.160823","article-title":"Idiosyncratic toxicity: A convergence of risk factors","volume":"58","year":"2007","journal-title":"Annu. Rev. Med"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOL.0b013e3282fee935","article-title":"Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis","volume":"19","year":"2008","journal-title":"Curr. Opin. Lipidol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B84","first-page":"81","article-title":"Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women","volume":"41","year":"2008","journal-title":"Biol. Res"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B85","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0016-5085(96)70028-8","article-title":"Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation","volume":"111","year":"1996","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B86","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","year":"2008","journal-title":"Am. J. Gastroenterol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(16)30011-5","article-title":"Pathogenesis and novel treatment options for non-alcoholic steatohepatitis","volume":"1","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B88","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/dmd.115.065979","article-title":"CYP3A activity and expression in nonalcoholic fatty liver disease","volume":"43","year":"2015","journal-title":"Drug Metab. Dispos"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B89","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/labinvest.2010.75","article-title":"Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice","volume":"90","year":"2010","journal-title":"Lab. Investig"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B90","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/labinvest.2011.2","article-title":"Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-fed db\/db mice","volume":"91","year":"2011","journal-title":"Lab. Investig"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B91","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/gut.2006.093260","article-title":"The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis","volume":"56","year":"2007","journal-title":"Gut"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B92","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1139\/o90-079","article-title":"Reduction in VLDL, but not HDL, in plasma of rats deficient in choline","volume":"68","year":"1990","journal-title":"Biochem. Cell Biol"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B93","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B94","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","year":"2013","journal-title":"Pharmacol. Ther"},{"key":"key\n\t\t\t\t20171227085525_kfx253-B95","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.taap.2010.03.016","article-title":"Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet","volume":"245","year":"2010","journal-title":"Toxicol. Appl. Pharmacol"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/161\/1\/23\/23043417\/kfx253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T23:06:47Z","timestamp":1570316807000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/toxsci\/article\/161\/1\/23\/4627695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,11,14]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfx253","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,11,14]]}}}